These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7563108)

  • 1. Preconditioning in man: progress and prospects.
    Lawson CS
    J Mol Cell Cardiol; 1995 Apr; 27(4):961-7. PubMed ID: 7563108
    [No Abstract]   [Full Text] [Related]  

  • 2. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection?
    Yellon DM; Baxter GF
    J Mol Cell Cardiol; 1995 Apr; 27(4):1023-34. PubMed ID: 7563099
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathophysiology of myocardial circulation. III. Preliminary results of ischemia using ischemia ("ischemic preconditioning")].
    Heusch G; Schulz R
    Dtsch Med Wochenschr; 1995 Jan; 120(1-2):35-6. PubMed ID: 7821203
    [No Abstract]   [Full Text] [Related]  

  • 4. Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?
    Baxter GF; Yellon DM
    Br J Clin Pharmacol; 1994 Nov; 38(5):381-7. PubMed ID: 7893577
    [No Abstract]   [Full Text] [Related]  

  • 5. Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine.
    Mullane K; Bullough D
    J Mol Cell Cardiol; 1995 Apr; 27(4):1041-54. PubMed ID: 7563101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does ischaemic preconditioning occur in the human heart?
    Lawson CS
    Cardiovasc Res; 1994 Oct; 28(10):1461-6. PubMed ID: 8001032
    [No Abstract]   [Full Text] [Related]  

  • 7. Ischemic preconditioning: a plea for rationally targeted clinical trials.
    Kloner RA; Speakman MT; Przyklenk K
    Cardiovasc Res; 2002 Aug; 55(3):526-33. PubMed ID: 12160949
    [No Abstract]   [Full Text] [Related]  

  • 8. [Postconditioning: a brief review].
    Schipke JD; Kerendi F; Gams E; Vinten-Johansen J
    Herz; 2006 Sep; 31(6):600-6. PubMed ID: 17036192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acidic postconditioning in ST-elevation myocardial infarction patients.
    Favaretto E; Tarantini G
    Cardiology; 2013; 125(2):94-5. PubMed ID: 23711733
    [No Abstract]   [Full Text] [Related]  

  • 10. Reperfusion duration paradox with late myocardial preconditioning in rabbits.
    Lellouche N; Tissier R; Souktani R; Giudicelli JF; Berdeaux A; Ghaleh B
    Eur J Pharmacol; 2002 Aug; 450(2):179-82. PubMed ID: 12206856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning in humans.
    Rezkalla SH; Kloner RA
    Heart Fail Rev; 2007 Dec; 12(3-4):201-6. PubMed ID: 17508280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential stress protein mRNA expression during early ischaemic preconditioning in the rabbit heart and its relationship to adenosine receptor function.
    Heads RJ; Latchman DS; Yellon DM
    J Mol Cell Cardiol; 1995 Oct; 27(10):2133-48. PubMed ID: 8576930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possibilities for the pharmacological exploitation of ischaemic preconditioning.
    Parratt JR
    J Mol Cell Cardiol; 1995 Apr; 27(4):991-1000. PubMed ID: 7563111
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoflurane and halothane increase adenosine triphosphate preservation, but do not provide additive recovery of function after ischemia, in preconditioned rat hearts.
    Boutros A; Wang J; Capuano C
    Anesthesiology; 1997 Jan; 86(1):109-17. PubMed ID: 9009946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia.
    Carr CS; Hill RJ; Masamune H; Kennedy SP; Knight DR; Tracey WR; Yellon DM
    Cardiovasc Res; 1997 Oct; 36(1):52-9. PubMed ID: 9415272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The uremic myocardium and ischemic tolerance: a world of difference.
    Dikow R; Hardt SE
    Circulation; 2012 Mar; 125(10):1215-6. PubMed ID: 22319108
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts.
    Hoshida S; Kuzuya T; Nishida M; Yamashita N; Oe H; Hori M; Kamada T; Tada M
    Cardiovasc Res; 1994 Jul; 28(7):1083-8. PubMed ID: 7954595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction.
    Madsen JK; Grande P; Saunamäki K; Thayssen P; Kassis E; Eriksen U; Rasmussen K; Haunsø S; Nielsen TT; Haghfelt T; Fritz-Hansen P; Hjelms E; Paulsen PK; Alstrup P; Arendrup H; Niebuhr-Jørgensen U; Andersen LI
    Circulation; 1997 Aug; 96(3):748-55. PubMed ID: 9264478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury.
    Vinten-Johansen J; Zhao ZQ; Jiang R; Zatta AJ; Dobson GP
    J Appl Physiol (1985); 2007 Oct; 103(4):1441-8. PubMed ID: 17615276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic preconditioning and glucose metabolism during low-flow ischemia: role of the adenosine A1 receptor.
    de Jonge R; de Jong JW
    Cardiovasc Res; 1999 Sep; 43(4):909-18. PubMed ID: 10615418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.